In the latest trading session, Moderna (MRNA) closed at $41.66, marking a +0.6% move from the previous day. The S&P 500 logs the best first week of a presidential term in four decades. Here are ...

In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against other firms end 2024 stronger with impressive gains. A lackluster trading persisted throughout the ...

What about an mRNA vaccine for H5N1? There isn't one yet, but several companies—including Moderna, Pfizer and GlaxoSmithKline (in collaboration with CureVac)—are working on such a shot.

Instead they end in a conserved stem–loop that interacts with stem–loop binding protein (SLBP), a factor involved in several steps of histone mRNA metabolism: pre-mRNA processing, translation ...

Making the world smarter, happier, and richer.

If you’re age 12 and older and originally got your Pfizer-BioNTech mRNA series at least five months ago, you’re eligible to get a Pfizer booster shot, the CDC says. Right now, the Pfizer ...

Good morning. I’m Teresa Hanafin, editor of Starting Point. Today I’m putting on my reporting cap to examine four viruses that are making people miserable this winter. You may have heard of ...

had suspended research on novel viruses and mRNA vaccine platforms, as well as most of its other work. The pharmaceutical companies Moderna and Pfizer, after downsizing their American operations ...

and spent $176 million to develop mRNA vaccines that could quickly be adapted to mutations in the virus, with late stage trials “beginning shortly,” the document says. Having measures in place ...

During a break in the hearing, Giuliani asked courtroom sketch artist Jane Rosenberg whether she would make him look "nice," said Rosenberg, who was documenting the hearing for Reuters.

Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, ...